A machine learning platform that predicts phenotypes from multi-omic data using ensemble methods. Built on the OutPredict system, it leverages random forest and Naive Bayes ensembles to identify causal, non-linear relationships between omic features and target traits, enabling better biological insight than traditional network-based approaches.
This offering provides a machine learning capability for predicting phenotypic outcomes directly from multi-omic input data, addressing the challenge of inferring causal relationships in biological systems. Traditional graph-based methods identify which omic features are relevant but fail to capture how those features influence a phenotype. This platform uses ensemble machine learning models to move beyond simple correlation, enabling prediction of outputs such as gene expression, drought tolerance, and other target traits from inputs including transcriptomic, genomic, and binding data. The approach is designed for moderate-sized datasets and is particularly well-suited to time-series experiments where sampling intervals align with transcription timescales.
Core methodology:
Validated applications:
The underlying technology has been validated through peer-reviewed publications, including work published in Nature Scientific Reports and BMC Bioinformatics. The OutPredict and EnsInfer systems have been benchmarked against single-method approaches and demonstrated superior performance in predicting expression levels and inferring causality from omic data. Current development focuses on extending the platform beyond transcription-level phenotypes to broader trait prediction, including drought tolerance, leveraging complementary datasets such as the 1001 Arabidopsis accession collection and multi-genotype rice data. The platform is ready for collaborative extension into new omic data types and target phenotypes through sponsored research partnerships.
New York University is a comprehensive private research university anchored in New York City, enrolling a large, diverse student body and operating a global network of campuses. Corporate engagement is enabled by co‑located engineering and computing hubs in Brooklyn and Manhattan with shared labs and facilities for prototyping and field pilots. Integration with a major hospital system supports clinical translation, IRB processes, and access to real‑world data under stringent governance. Proximity to leading industries and a mature sponsored‑research function streamline scoping, NDAs, MSAs, and talent pipelines. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and DOD, and a dedicated technology transfer office manages IP, licensing, and startup creation.